Online weight loss treatment in Connecticut
Surfbound connects eligible adults in Connecticut with licensed providers for online GLP-1 weight-loss treatment review. Semaglutide $169/mo and tirzepatide $219/mo. Prescriptions are not guaranteed and are issued only when medically appropriate.
No in-person visit. A licensed provider reviews your intake. A prescription is not guaranteed.
Can I start online GLP-1 weight loss treatment in Connecticut?
Yes. Eligible adults across Connecticut can begin an online GLP-1 weight-loss evaluation with Surfbound without an in-person visit. A licensed provider credentialed in Connecticut reviews your health intake and, if treatment is medically appropriate, your prescription may be sent to a licensed pharmacy and shipped discreetly to your Connecticut address. Semaglutide is $169/mo and tirzepatide is $219/mo; a prescription is never guaranteed.
The Constitution State · Northeast region. A compact state with strong telehealth regulation and limited in-person obesity-medicine options. No office visit needed across the NYC commuter corridor.
Coverage across Connecticut
Surfbound lists 6 Connecticut cities with a dedicated local page. Care is delivered online, so you can also start from anywhere else in the state.
Provider access & processPricing and insurance
Semaglutide is $169/mo and tirzepatide is $219/mo. Clear pricing shown before checkout. Surfbound does not accept insurance at this time.
Shipping to Connecticut
Prescriptions for Connecticut patients are routed to a licensed compounding pharmacy. Dispatch follows provider approval, and delivery time varies with distance across the Northeast region, from Hartford, New Haven, Stamford to rural addresses, plus pharmacy and carrier schedules. Tracking is provided by email.
What's included in every Connecticut plan
One flat monthly price covers the licensed provider review, medication if prescribed, and discreet shipping. There is no separate membership fee.
Connecticut coverage & access
Practical answers about where you can start, how shipping works, and how to compare complete costs in Connecticut. The Connecticut provider access & process page covers the clinical steps in detail.
Surfbound lists 6 Connecticut cities with a dedicated local page. Because care is delivered online, you can start from anywhere in Connecticut — the city list is a navigation aid, not a limit on where you can begin.
The Connecticut telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in Connecticut. You complete a health intake online, and a licensed provider credentialed in Connecticut reviews your information remotely.
Connecticut permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in Connecticut may review a Connecticut patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in Connecticut” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active Connecticut license issued by the Connecticut Medical Examining Board, and any pharmacy filling your prescription must be licensed in Connecticut. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in Connecticut” section on this page.
Across Connecticut, semaglutide runs $169/mo and tirzepatide $219/mo — one flat rate that covers the Connecticut-licensed provider review. There is no membership fee, and the total appears before checkout.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
No — in Connecticut, medication is dispensed only when the reviewing provider finds treatment medically appropriate.
Yes — Connecticut residents can transfer an existing GLP-1 plan. Note your medication and dose in the intake, and the reviewing Connecticut provider determines the prescription after assessing whether a dose match is appropriate.
The GLP-1 total-cost calculator compares equal monthly recurring cost — membership, shipping and dose surcharges for any plan — against Surfbound's flat Connecticut rate, so Connecticut residents compare complete costs rather than a headline number.
Yes. Compounded semaglutide is offered to Connecticut residents at a flat monthly rate that includes the provider review. A Connecticut-licensed provider decides whether it is appropriate, and a licensed compounding pharmacy ships to your address if it is prescribed. Compounded semaglutide is not FDA-approved.
Tirzepatide is available to Connecticut residents and reviewed the same way as semaglutide. The provider review is included in the monthly price, and treatment is dispensed only when a Connecticut-licensed provider finds it appropriate. Compounded tirzepatide is not FDA-approved.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and Connecticut residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the Connecticut-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in Connecticut. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed Connecticut provider approves your medication. A compact state with strong telehealth regulation and limited in-person obesity-medicine options.
Yes. Connecticut residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed Connecticut provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across Connecticut with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A Connecticut-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. Connecticut residents complete a short online intake on their own schedule, and a Connecticut-licensed provider reviews it remotely. If prescribed, medication ships to your door — no clinic, waiting room, or daytime appointment. A compact state with strong telehealth regulation and limited in-person obesity-medicine options. No office visit needed across the NYC commuter corridor.
Yes. Men across Connecticut begin with a private online intake, a licensed Connecticut provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches Connecticut residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Telehealth rules in Connecticut
What governs a provider treating a Connecticut patient online, and where you can check it yourself.
State medical board
Connecticut Medical Examining BoardConnecticut Medical Examining Board licenses the providers who review Connecticut intakes. The board site carries the current licensing and practice requirements.
Telehealth statute or rule
Connecticut General Statutes Chapter 378Opens the official Connecticut code. Search the statute or rule named above for the full text rather than relying on any summary.
Licensure requirement
A clinician must hold an active Connecticut license to evaluate or treat a patient who is physically located in Connecticut. Every Connecticut intake is routed to a provider credentialed in Connecticut, and a prescription is issued only when that provider determines treatment is medically appropriate.
Connecticut law permits telemedicine prescribing when a proper provider-patient relationship exists. The online health intake and provider review establishes this relationship consistent with Connecticut standards.
Surfbound is an online service. We do not have physical offices in Connecticut. Licensed providers review health information online. A prescription is not guaranteed.
Medical sources & references
Surfbound providers are licensed to practice in Connecticut and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official Connecticut state government agency. Provider licensure in Connecticut is governed by the Connecticut Medical Examining Board.
- FDA — Human Drug CompoundingFDA guidance clarifying that compounded medications are not FDA-approved.
- FDA — Compounding: Questions and AnswersConfirms compounded drugs are not reviewed by FDA for safety or effectiveness.
- NIDDK (NIH) — Prescription Medications to Treat Overweight & ObesityNIH guidance on GLP-1 receptor agonists for medical weight management.
- CDC — Adult Obesity FactsNational adult obesity prevalence data referenced for regional context.
- ASMBS — American Society for Metabolic and Bariatric SurgeryProfessional guidance on metabolic and bariatric medicine.
- MedlinePlus (NIH) — Weight ControlConsumer health information on weight management from the National Library of Medicine.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.